Skip to main content
Erschienen in: European Radiology 9/2018

09.04.2018 | Head and Neck

MR-based radiomics signature in differentiating ocular adnexal lymphoma from idiopathic orbital inflammation

verfasst von: Jian Guo, Zhenyu Liu, Chen Shen, Zheng Li, Fei Yan, Jie Tian, Junfang Xian

Erschienen in: European Radiology | Ausgabe 9/2018

Einloggen, um Zugang zu erhalten

Abstract

Objectives

To assess the value of the MR-based radiomics signature in differentiating ocular adnexal lymphoma (OAL) and idiopathic orbital inflammation (IOI).

Methods

One hundred fifty-seven patients with pathology-proven OAL (84 patients) and IOI (73 patients) were divided into primary and validation cohorts. Eight hundred six radiomics features were extracted from morphological MR images. The least absolute shrinkage and selection operator (LASSO) procedure and linear combination were used to select features and build radiomics signature for discriminating OAL from IOI. Discriminating performance was assessed by the area under the receiver-operating characteristic curve (AUC). The predictive results were compared with the assessment of radiologists by chi-square test.

Results

Five radiomics features were included in the radiomics signature, which differentiated OAL from IOI with an AUC of 0.74 and 0.73 in the primary and validation cohorts respectively. There was a significant difference between the classification results of the radiomics signature and those of a radiology resident (p < 0.05), although there was no significant difference between the results of the radiomics signature and those of a more experienced radiologist (p > 0.05).

Conclusions

Radiomics features have the potential to differentiate OAL from IOI.

Key Points

• Clinical and imaging findings of OAL and IOI often overlap, which makes diagnosis difficult.
• Radiomics features can potentially differentiate OAL from IOI non invasively.
• The radiomics signature discriminates OAL from IOI at the same level as an experienced radiologist.
Literatur
1.
Zurück zum Zitat Rosado MF, Byrne GE, Ding F et al (2006) Ocular adnexal lymphoma: a clinicopathologic study of a large cohort of patients with no evidence for an association with Chlamydia psittaci. Blood 107:467–472CrossRefPubMedPubMedCentral Rosado MF, Byrne GE, Ding F et al (2006) Ocular adnexal lymphoma: a clinicopathologic study of a large cohort of patients with no evidence for an association with Chlamydia psittaci. Blood 107:467–472CrossRefPubMedPubMedCentral
2.
Zurück zum Zitat Sjö LD (2009) Ophthalmic lymphoma: epidemiology and pathogenesis. Acta Ophthalmologica 87:1–20CrossRefPubMed Sjö LD (2009) Ophthalmic lymphoma: epidemiology and pathogenesis. Acta Ophthalmologica 87:1–20CrossRefPubMed
3.
Zurück zum Zitat Shields JA, Shields CL, Scartozzi R (2004) Survey of 1264 patients with orbital tumors and simulating lesions: The 2002 Montgomery Lecture, part 1. Ophthalmology 111:997–1008CrossRefPubMed Shields JA, Shields CL, Scartozzi R (2004) Survey of 1264 patients with orbital tumors and simulating lesions: The 2002 Montgomery Lecture, part 1. Ophthalmology 111:997–1008CrossRefPubMed
4.
Zurück zum Zitat Ferreri AJ, Dolcetti R, Du MQ et al (2008) Ocular adnexal MALT lymphoma: an intriguing model for antigen-driven lymphomagenesis and microbial-targeted therapy. Ann Oncol 19:835–846CrossRefPubMed Ferreri AJ, Dolcetti R, Du MQ et al (2008) Ocular adnexal MALT lymphoma: an intriguing model for antigen-driven lymphomagenesis and microbial-targeted therapy. Ann Oncol 19:835–846CrossRefPubMed
5.
Zurück zum Zitat Woolf DK, Ahmed M, Plowman PN (2012) Primary lymphoma of the ocular adnexa (orbital lymphoma) and primary intraocular lymphoma. Clin Oncol (R Coll Radiol) 24:339–344CrossRef Woolf DK, Ahmed M, Plowman PN (2012) Primary lymphoma of the ocular adnexa (orbital lymphoma) and primary intraocular lymphoma. Clin Oncol (R Coll Radiol) 24:339–344CrossRef
6.
Zurück zum Zitat Kharod SM, Herman MP, Morris CG, Lightsey J, Mendenhall WM, Mendenhall NP (2018) Radiotherapy in the management of orbital lymphoma: a single institution's experience over 4 decades. Am J Clin Oncol 41:100–106PubMed Kharod SM, Herman MP, Morris CG, Lightsey J, Mendenhall WM, Mendenhall NP (2018) Radiotherapy in the management of orbital lymphoma: a single institution's experience over 4 decades. Am J Clin Oncol 41:100–106PubMed
7.
Zurück zum Zitat Shikishima K, Kawai K, Kitahara K (2006) Pathological evaluation of orbital tumours in Japan: analysis of a large case series and 1379 cases reported in the Japanese literature. Clin Exp Ophthalmol 34:239–244CrossRefPubMed Shikishima K, Kawai K, Kitahara K (2006) Pathological evaluation of orbital tumours in Japan: analysis of a large case series and 1379 cases reported in the Japanese literature. Clin Exp Ophthalmol 34:239–244CrossRefPubMed
8.
Zurück zum Zitat Rubin PA, Foster CS (2004) Etiology and management of idiopathic orbital inflammation. Am J Ophthalmol 138:1041–1043CrossRefPubMed Rubin PA, Foster CS (2004) Etiology and management of idiopathic orbital inflammation. Am J Ophthalmol 138:1041–1043CrossRefPubMed
9.
Zurück zum Zitat Swamy BN, McCluskey P, Nemet A et al (2007) Idiopathic orbital inflammatory syndrome: clinical features and treatment outcomes. Br J Ophthalmol 91:1667–1670CrossRefPubMedPubMedCentral Swamy BN, McCluskey P, Nemet A et al (2007) Idiopathic orbital inflammatory syndrome: clinical features and treatment outcomes. Br J Ophthalmol 91:1667–1670CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Dagi Glass LR, Freitag SK (2016) Orbital inflammation: Corticosteroids first. Survey of Ophthalmology 61:670–673CrossRefPubMed Dagi Glass LR, Freitag SK (2016) Orbital inflammation: Corticosteroids first. Survey of Ophthalmology 61:670–673CrossRefPubMed
11.
Zurück zum Zitat Mombaerts I, Rose GE, Garrity JA (2016) Orbital Inflammation: Biopsy first. Survey of Ophthalmology 61:664-669 Mombaerts I, Rose GE, Garrity JA (2016) Orbital Inflammation: Biopsy first. Survey of Ophthalmology 61:664-669
12.
Zurück zum Zitat Cytryn AS, Putterman AM, Schneck GL, Beckman E, Valvassori GE (1997) Predictability of magnetic resonance imaging in differentiation of orbital lymphoma from orbital inflammatory syndrome. Ophthal Plast Reconstr Surg 13:129–134CrossRefPubMed Cytryn AS, Putterman AM, Schneck GL, Beckman E, Valvassori GE (1997) Predictability of magnetic resonance imaging in differentiation of orbital lymphoma from orbital inflammatory syndrome. Ophthal Plast Reconstr Surg 13:129–134CrossRefPubMed
13.
Zurück zum Zitat Haradome K, Haradome H, Usui Y et al (2014) Orbital lymphoproliferative disorders (OLPDs): value of MR imaging for differentiating orbital lymphoma from benign OPLDs. AJNR Am J Neuroradiol 35:1976–1982CrossRefPubMed Haradome K, Haradome H, Usui Y et al (2014) Orbital lymphoproliferative disorders (OLPDs): value of MR imaging for differentiating orbital lymphoma from benign OPLDs. AJNR Am J Neuroradiol 35:1976–1982CrossRefPubMed
14.
Zurück zum Zitat Xian J, Zhang Z, Wang Z et al (2010) Value of MR imaging in the differentiation of benign and malignant orbital tumors in adults. Eur Radiol 20:1692–1702CrossRefPubMedPubMedCentral Xian J, Zhang Z, Wang Z et al (2010) Value of MR imaging in the differentiation of benign and malignant orbital tumors in adults. Eur Radiol 20:1692–1702CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Warner MA, Weber AL, Jakobiec FA (1996) Benign and malignant tumors of the orbital cavity including the lacrimal gland. Neuroimaging Clin N Am 6:123–142PubMed Warner MA, Weber AL, Jakobiec FA (1996) Benign and malignant tumors of the orbital cavity including the lacrimal gland. Neuroimaging Clin N Am 6:123–142PubMed
16.
Zurück zum Zitat Roshdy N, Shahin M, Kishk H et al (2010) MRI in diagnosis of orbital masses. Curr Eye Res 35:986–991CrossRefPubMed Roshdy N, Shahin M, Kishk H et al (2010) MRI in diagnosis of orbital masses. Curr Eye Res 35:986–991CrossRefPubMed
17.
Zurück zum Zitat Sullivan TJ, Valenzuela AA (2006) Imaging features of ocular adnexal lymphoproliferative disease. Eye 20:1189–1195CrossRefPubMed Sullivan TJ, Valenzuela AA (2006) Imaging features of ocular adnexal lymphoproliferative disease. Eye 20:1189–1195CrossRefPubMed
18.
Zurück zum Zitat Uehara F, Ohba N (2002) Diagnostic imaging in patients with orbital cellulitis and inflammatory pseudotumor. Int Ophthalmol Clin 42:133–142CrossRefPubMed Uehara F, Ohba N (2002) Diagnostic imaging in patients with orbital cellulitis and inflammatory pseudotumor. Int Ophthalmol Clin 42:133–142CrossRefPubMed
19.
Zurück zum Zitat Politi LS, Forghani R, Godi C et al (2010) Ocular adnexal lymphoma: diffusion-weighted MR imaging for differential diagnosis and therapeutic monitoring. Radiology 256:565–574CrossRefPubMed Politi LS, Forghani R, Godi C et al (2010) Ocular adnexal lymphoma: diffusion-weighted MR imaging for differential diagnosis and therapeutic monitoring. Radiology 256:565–574CrossRefPubMed
20.
Zurück zum Zitat Fatima Z, Ichikawa T, Ishigame K et al (2014) Orbital masses: the usefulness of diffusion-weighted imaging in lesion categorization. Clin Neuroradiol 24:129–134CrossRefPubMed Fatima Z, Ichikawa T, Ishigame K et al (2014) Orbital masses: the usefulness of diffusion-weighted imaging in lesion categorization. Clin Neuroradiol 24:129–134CrossRefPubMed
21.
Zurück zum Zitat Kapur R, Sepahdari AR, Mafee MF et al (2009) MR imaging of orbital inflammatory syndrome, orbital cellulitis, and orbital lymphoid lesions: the role of diffusion-weighted imaging. AJNR Am J Neuroradiol 30:64–70CrossRefPubMed Kapur R, Sepahdari AR, Mafee MF et al (2009) MR imaging of orbital inflammatory syndrome, orbital cellulitis, and orbital lymphoid lesions: the role of diffusion-weighted imaging. AJNR Am J Neuroradiol 30:64–70CrossRefPubMed
22.
Zurück zum Zitat Sepahdari AR, Aakalu VK, Setabutr P, Shiehmorteza M, Naheedy JH, Mafee MF (2010) Indeterminate orbital masses: restricted diffusion at MR imaging with echo-planar diffusion-weighted imaging predicts malignancy. Radiology 256:554–564CrossRefPubMed Sepahdari AR, Aakalu VK, Setabutr P, Shiehmorteza M, Naheedy JH, Mafee MF (2010) Indeterminate orbital masses: restricted diffusion at MR imaging with echo-planar diffusion-weighted imaging predicts malignancy. Radiology 256:554–564CrossRefPubMed
23.
Zurück zum Zitat Purohit BS, Vargas MI, Ailianou A et al (2016) Orbital tumours and tumour-like lesions: exploring the armamentarium of multiparametric imaging. Insights Imaging 7:43–68CrossRefPubMed Purohit BS, Vargas MI, Ailianou A et al (2016) Orbital tumours and tumour-like lesions: exploring the armamentarium of multiparametric imaging. Insights Imaging 7:43–68CrossRefPubMed
24.
Zurück zum Zitat Sun B, Song L, Wang X et al (2017) Lymphoma and inflammation in the orbit: Diagnostic performance with diffusion-weighted imaging and dynamic contrast-enhanced MRI. J Magn Reson Imaging 45:1438–1445CrossRefPubMed Sun B, Song L, Wang X et al (2017) Lymphoma and inflammation in the orbit: Diagnostic performance with diffusion-weighted imaging and dynamic contrast-enhanced MRI. J Magn Reson Imaging 45:1438–1445CrossRefPubMed
25.
Zurück zum Zitat Xu XQ, Hu H, Liu H et al (2017) Benign and malignant orbital lymphoproliferative disorders: differentiating using multiparametric MRI at 3.0T. J Magn Reson Imaging 45:167–176CrossRefPubMed Xu XQ, Hu H, Liu H et al (2017) Benign and malignant orbital lymphoproliferative disorders: differentiating using multiparametric MRI at 3.0T. J Magn Reson Imaging 45:167–176CrossRefPubMed
26.
Zurück zum Zitat Lambin P, Riosvelazquez E, Leijenaar RTH et al (2012) Radiomics: Extracting more information from medical images using advanced feature analysis. Eur J Cancer 48:441–446CrossRefPubMedPubMedCentral Lambin P, Riosvelazquez E, Leijenaar RTH et al (2012) Radiomics: Extracting more information from medical images using advanced feature analysis. Eur J Cancer 48:441–446CrossRefPubMedPubMedCentral
28.
Zurück zum Zitat Huang Y, Liu Z, He L et al (2016) Radiomics signature: a potential biomarker for the prediction of disease-free survival in early-stage (I or II) non-small cell lung cancer. Radiology 281:947–957CrossRefPubMed Huang Y, Liu Z, He L et al (2016) Radiomics signature: a potential biomarker for the prediction of disease-free survival in early-stage (I or II) non-small cell lung cancer. Radiology 281:947–957CrossRefPubMed
29.
Zurück zum Zitat Huang YQ, Liang CH, He L et al (2016) Development and validation of a radiomics nomogram for preoperative prediction of lymph node metastasis in colorectal cancer. J Clin Oncol 34:2157–2164CrossRefPubMed Huang YQ, Liang CH, He L et al (2016) Development and validation of a radiomics nomogram for preoperative prediction of lymph node metastasis in colorectal cancer. J Clin Oncol 34:2157–2164CrossRefPubMed
30.
Zurück zum Zitat Parmar C, Leijenaar RT, Grossmann P et al (2015) Radiomic feature clusters and prognostic signatures specific for lung and head & neck cancer. Sci Rep 5:11044CrossRefPubMedPubMedCentral Parmar C, Leijenaar RT, Grossmann P et al (2015) Radiomic feature clusters and prognostic signatures specific for lung and head & neck cancer. Sci Rep 5:11044CrossRefPubMedPubMedCentral
32.
Zurück zum Zitat Nie K, Shi L, Chen Q et al (2016) Rectal cancer: assessment of neoadjuvant chemoradiation outcome based on radiomics of multiparametric MRI. Clin Cancer Res 22:5256–5264CrossRefPubMed Nie K, Shi L, Chen Q et al (2016) Rectal cancer: assessment of neoadjuvant chemoradiation outcome based on radiomics of multiparametric MRI. Clin Cancer Res 22:5256–5264CrossRefPubMed
33.
Zurück zum Zitat Aerts HJ, Velazquez ER, Leijenaar RT et al (2014) Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach. Nat Commun 5:4006CrossRefPubMedPubMedCentral Aerts HJ, Velazquez ER, Leijenaar RT et al (2014) Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach. Nat Commun 5:4006CrossRefPubMedPubMedCentral
34.
Zurück zum Zitat Bayanati H, Thornhill RE, Souza CA et al (2014) Quantitative CT texture and shape analysis: Can it differentiate benign and malignant mediastinal lymph nodes in patients with primary lung cancer? Eur Radiol 25:480–487CrossRefPubMed Bayanati H, Thornhill RE, Souza CA et al (2014) Quantitative CT texture and shape analysis: Can it differentiate benign and malignant mediastinal lymph nodes in patients with primary lung cancer? Eur Radiol 25:480–487CrossRefPubMed
35.
Zurück zum Zitat Nie K, Chen JH, Yu HJ, Chu Y, Nalcioglu O, Su MY (2008) Quantitative analysis of lesion morphology and texture features for diagnostic prediction in breast MRI. Acad Radiol 15:1513–1525CrossRefPubMedPubMedCentral Nie K, Chen JH, Yu HJ, Chu Y, Nalcioglu O, Su MY (2008) Quantitative analysis of lesion morphology and texture features for diagnostic prediction in breast MRI. Acad Radiol 15:1513–1525CrossRefPubMedPubMedCentral
36.
Zurück zum Zitat Juntu J, Sijbers J, De Backer S, Rajan J, Van Dyck D (2010) Machine learning study of several classifiers trained with texture analysis features to differentiate benign from malignant soft-tissue tumors in T1-MRI images. J Magn Reson Imaging 31:680–689CrossRefPubMed Juntu J, Sijbers J, De Backer S, Rajan J, Van Dyck D (2010) Machine learning study of several classifiers trained with texture analysis features to differentiate benign from malignant soft-tissue tumors in T1-MRI images. J Magn Reson Imaging 31:680–689CrossRefPubMed
37.
Zurück zum Zitat Thornhill RE, Golfam M, Sheikh A et al (2014) Differentiation of lipoma from liposarcoma on MRI using texture and shape analysis. Acad Radiol 21:1185–1194CrossRefPubMed Thornhill RE, Golfam M, Sheikh A et al (2014) Differentiation of lipoma from liposarcoma on MRI using texture and shape analysis. Acad Radiol 21:1185–1194CrossRefPubMed
38.
Zurück zum Zitat Fruehwald-Pallamar J, Hesselink JR, Mafee MF, Holzer-Fruehwald L, Czerny C, Mayerhoefer ME (2016) Texture-based analysis of 100 MR examinations of head and neck tumors - Is it possible to discriminate between benign and malignant masses in a multicenter trial? Rofo 188:195–202PubMed Fruehwald-Pallamar J, Hesselink JR, Mafee MF, Holzer-Fruehwald L, Czerny C, Mayerhoefer ME (2016) Texture-based analysis of 100 MR examinations of head and neck tumors - Is it possible to discriminate between benign and malignant masses in a multicenter trial? Rofo 188:195–202PubMed
39.
40.
Zurück zum Zitat Li Z, Mao Y, Li H, Yu G, Wan H, Li B (2015) Differentiating brain metastases from different pathological types of lung cancers using texture analysis of T1 postcontrast MR. Magne Reson Med 76:1410–1419CrossRef Li Z, Mao Y, Li H, Yu G, Wan H, Li B (2015) Differentiating brain metastases from different pathological types of lung cancers using texture analysis of T1 postcontrast MR. Magne Reson Med 76:1410–1419CrossRef
41.
Zurück zum Zitat Zhang B, Tian J, Dong D et al (2017) Radiomics features of multiparametric MRI as novel prognostic factors in advanced nasopharyngeal carcinoma. Clin Cancer Res 23:4259–4269CrossRefPubMed Zhang B, Tian J, Dong D et al (2017) Radiomics features of multiparametric MRI as novel prognostic factors in advanced nasopharyngeal carcinoma. Clin Cancer Res 23:4259–4269CrossRefPubMed
42.
Zurück zum Zitat Ganeshan B, Abaleke S, Young RC, Chatwin CR, Miles KA (2010) Texture analysis of non-small cell lung cancer on unenhanced computed tomography: initial evidence for a relationship with tumour glucose metabolism and stage. Cancer Imaging 10:137–143CrossRefPubMedPubMedCentral Ganeshan B, Abaleke S, Young RC, Chatwin CR, Miles KA (2010) Texture analysis of non-small cell lung cancer on unenhanced computed tomography: initial evidence for a relationship with tumour glucose metabolism and stage. Cancer Imaging 10:137–143CrossRefPubMedPubMedCentral
43.
Zurück zum Zitat Ganeshan B, Miles KA, Young RC, Chatwin CR (2007) In search of biologic correlates for liver texture on portal-phase CT. Acad Radiol 14:1058–1068CrossRefPubMed Ganeshan B, Miles KA, Young RC, Chatwin CR (2007) In search of biologic correlates for liver texture on portal-phase CT. Acad Radiol 14:1058–1068CrossRefPubMed
44.
Zurück zum Zitat Ganeshan B, Skogen K, Pressney I, Coutroubis D, Miles K (2012) Tumour heterogeneity in oesophageal cancer assessed by CT texture analysis: preliminary evidence of an association with tumour metabolism, stage, and survival. Clin Radiol 67:157–164CrossRefPubMed Ganeshan B, Skogen K, Pressney I, Coutroubis D, Miles K (2012) Tumour heterogeneity in oesophageal cancer assessed by CT texture analysis: preliminary evidence of an association with tumour metabolism, stage, and survival. Clin Radiol 67:157–164CrossRefPubMed
45.
Zurück zum Zitat Ganeshan B, Panayiotou E, Burnand K, Dizdarevic S, Miles K (2012) Tumour heterogeneity in non-small cell lung carcinoma assessed by CT texture analysis: a potential marker of survival. Eur Radiol 22:796–802CrossRefPubMed Ganeshan B, Panayiotou E, Burnand K, Dizdarevic S, Miles K (2012) Tumour heterogeneity in non-small cell lung carcinoma assessed by CT texture analysis: a potential marker of survival. Eur Radiol 22:796–802CrossRefPubMed
46.
Zurück zum Zitat Skogen K, Ganeshan B, Good C, Critchley G, Miles K (2013) Measurements of heterogeneity in gliomas on computed tomography relationship to tumour grade. J Neurooncol 111:213–219CrossRefPubMed Skogen K, Ganeshan B, Good C, Critchley G, Miles K (2013) Measurements of heterogeneity in gliomas on computed tomography relationship to tumour grade. J Neurooncol 111:213–219CrossRefPubMed
47.
Zurück zum Zitat Frighetto-Pereira L, Rangayyan RM, Metzner GA (2016) Shape, texture and statistical features for classification of benign and malignant vertebral compression fractures in magnetic resonance images. Computers in Biology & Medicine 73:147–156CrossRef Frighetto-Pereira L, Rangayyan RM, Metzner GA (2016) Shape, texture and statistical features for classification of benign and malignant vertebral compression fractures in magnetic resonance images. Computers in Biology & Medicine 73:147–156CrossRef
48.
Zurück zum Zitat Woods BJ, Clymer BD, Kurc T et al (2007) Malignant-lesion segmentation using 4D co-occurrence texture analysis applied to dynamic contrast-enhanced magnetic resonance breast image data. J Magn Reson Imaging 25:495–501CrossRefPubMed Woods BJ, Clymer BD, Kurc T et al (2007) Malignant-lesion segmentation using 4D co-occurrence texture analysis applied to dynamic contrast-enhanced magnetic resonance breast image data. J Magn Reson Imaging 25:495–501CrossRefPubMed
49.
Zurück zum Zitat Sasaguri K, Takahashi N, Takeuchi M, Carter RE, Leibovich BC, Kawashima A (2016) Differentiation of benign from metastatic adrenal masses in patients with renal cell carcinoma on contrast-enhanced CT. AJR Am J Roentgenol 207:1031–1038CrossRefPubMed Sasaguri K, Takahashi N, Takeuchi M, Carter RE, Leibovich BC, Kawashima A (2016) Differentiation of benign from metastatic adrenal masses in patients with renal cell carcinoma on contrast-enhanced CT. AJR Am J Roentgenol 207:1031–1038CrossRefPubMed
50.
Zurück zum Zitat Fruehwald-Pallamar J, Czerny C, Holzer-Fruehwald L et al (2013) Texture-based and diffusion-weighted discrimination of parotid gland lesions on MR images at 3.0 Tesla. NMR Biomed 26:1372–1379CrossRefPubMed Fruehwald-Pallamar J, Czerny C, Holzer-Fruehwald L et al (2013) Texture-based and diffusion-weighted discrimination of parotid gland lesions on MR images at 3.0 Tesla. NMR Biomed 26:1372–1379CrossRefPubMed
51.
Zurück zum Zitat Mueller-Using S, Feldt T, Sarfo FS, Eberhardt KA (2016) Factors associated with performing tuberculosis screening of HIV-positive patients in Ghana: LASSO-based predictor selection in a large public health data set. BMC Public Health 16:563CrossRefPubMedPubMedCentral Mueller-Using S, Feldt T, Sarfo FS, Eberhardt KA (2016) Factors associated with performing tuberculosis screening of HIV-positive patients in Ghana: LASSO-based predictor selection in a large public health data set. BMC Public Health 16:563CrossRefPubMedPubMedCentral
52.
Zurück zum Zitat Gibbs P, Turnbull LW (2003) Textural analysis of contrast-enhanced MR images of the breast. Magn Reson Med 50:92–98CrossRefPubMed Gibbs P, Turnbull LW (2003) Textural analysis of contrast-enhanced MR images of the breast. Magn Reson Med 50:92–98CrossRefPubMed
53.
Zurück zum Zitat Xu R, Kido S, Suga K et al (2014) Texture analysis on (18)F-FDG PET/CT images to differentiate malignant and benign bone and soft-tissue lesions. Ann Nucl Med 28:926–935CrossRefPubMed Xu R, Kido S, Suga K et al (2014) Texture analysis on (18)F-FDG PET/CT images to differentiate malignant and benign bone and soft-tissue lesions. Ann Nucl Med 28:926–935CrossRefPubMed
54.
Zurück zum Zitat Way TW, Hadjiiski LM, Sahiner B et al (2006) Computer-aided diagnosis of pulmonary nodules on CT scans: segmentation and classification using 3D active contours. Medical Physics 33:2323–2337CrossRefPubMedPubMedCentral Way TW, Hadjiiski LM, Sahiner B et al (2006) Computer-aided diagnosis of pulmonary nodules on CT scans: segmentation and classification using 3D active contours. Medical Physics 33:2323–2337CrossRefPubMedPubMedCentral
55.
Zurück zum Zitat Sepahdari AR, Politi LS, Aakalu VK, Kim HJ, Razek AA (2014) Diffusion-weighted imaging of orbital masses: multi-institutional data support a 2-ADC threshold model to categorize lesions as benign, malignant, or indeterminate. AJNR Am J Neuroradiol 35:170–175CrossRefPubMed Sepahdari AR, Politi LS, Aakalu VK, Kim HJ, Razek AA (2014) Diffusion-weighted imaging of orbital masses: multi-institutional data support a 2-ADC threshold model to categorize lesions as benign, malignant, or indeterminate. AJNR Am J Neuroradiol 35:170–175CrossRefPubMed
Metadaten
Titel
MR-based radiomics signature in differentiating ocular adnexal lymphoma from idiopathic orbital inflammation
verfasst von
Jian Guo
Zhenyu Liu
Chen Shen
Zheng Li
Fei Yan
Jie Tian
Junfang Xian
Publikationsdatum
09.04.2018
Verlag
Springer Berlin Heidelberg
Erschienen in
European Radiology / Ausgabe 9/2018
Print ISSN: 0938-7994
Elektronische ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-018-5381-7

Weitere Artikel der Ausgabe 9/2018

European Radiology 9/2018 Zur Ausgabe

Screening-Mammografie offenbart erhöhtes Herz-Kreislauf-Risiko

26.04.2024 Mammografie Nachrichten

Routinemäßige Mammografien helfen, Brustkrebs frühzeitig zu erkennen. Anhand der Röntgenuntersuchung lassen sich aber auch kardiovaskuläre Risikopatientinnen identifizieren. Als zuverlässiger Anhaltspunkt gilt die Verkalkung der Brustarterien.

S3-Leitlinie zu Pankreaskrebs aktualisiert

23.04.2024 Pankreaskarzinom Nachrichten

Die Empfehlungen zur Therapie des Pankreaskarzinoms wurden um zwei Off-Label-Anwendungen erweitert. Und auch im Bereich der Früherkennung gibt es Aktualisierungen.

Fünf Dinge, die im Kindernotfall besser zu unterlassen sind

18.04.2024 Pädiatrische Notfallmedizin Nachrichten

Im Choosing-Wisely-Programm, das für die deutsche Initiative „Klug entscheiden“ Pate gestanden hat, sind erstmals Empfehlungen zum Umgang mit Notfällen von Kindern erschienen. Fünf Dinge gilt es demnach zu vermeiden.

„Nur wer sich gut aufgehoben fühlt, kann auch für Patientensicherheit sorgen“

13.04.2024 Klinik aktuell Kongressbericht

Die Teilnehmer eines Forums beim DGIM-Kongress waren sich einig: Fehler in der Medizin sind häufig in ungeeigneten Prozessen und mangelnder Kommunikation begründet. Gespräche mit Patienten und im Team können helfen.

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.